Medikaloka Hermina PT (HEAL) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.032x

Based on the latest financial reports, Medikaloka Hermina PT (HEAL) has a cash flow conversion efficiency ratio of 0.032x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp225.37 Billion ≈ $13.21 Million USD) by net assets (Rp7.01 Trillion ≈ $410.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Medikaloka Hermina PT net asset quality index to measure how much of total assets are equity-financed.

Medikaloka Hermina PT - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how Medikaloka Hermina PT's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Medikaloka Hermina PT cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

Medikaloka Hermina PT Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Medikaloka Hermina PT ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Patria Investments Ltd
NASDAQ:PAX
0.058x
Baotailong New Materials Co Ltd
SHG:601011
-0.012x
SS Innovations International Inc. Common Stock
NASDAQ:SSII
-0.042x
Regal Partners Ltd
AU:RPL
0.048x
Kardemir Karabuk Demir Celik Sanayi ve Ticaret AS Class D
IS:KRDMD
0.031x
WhiteFiber, Inc. Ordinary Shares
NASDAQ:WYFI
-0.035x
National Grid PLC
LSE:NG
0.076x
Hangzhou Jiebai Group Co Ltd
SHG:600814
0.048x

Annual Cash Flow Conversion Efficiency for Medikaloka Hermina PT (2015–2024)

The table below shows the annual cash flow conversion efficiency of Medikaloka Hermina PT from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Medikaloka Hermina PT worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 Rp5.87 Trillion
≈ $343.74 Million
Rp1.14 Trillion
≈ $66.66 Million
0.194x -23.61%
2023-12-31 Rp5.20 Trillion
≈ $304.60 Million
Rp1.32 Trillion
≈ $77.33 Million
0.254x +136.20%
2022-12-31 Rp4.69 Trillion
≈ $274.55 Million
Rp503.58 Billion
≈ $29.51 Million
0.107x -74.60%
2021-12-31 Rp4.39 Trillion
≈ $257.02 Million
Rp1.86 Trillion
≈ $108.77 Million
0.423x +27.07%
2020-12-31 Rp3.38 Trillion
≈ $198.18 Million
Rp1.13 Trillion
≈ $66.01 Million
0.333x +60.80%
2019-12-31 Rp2.76 Trillion
≈ $161.98 Million
Rp572.58 Billion
≈ $33.55 Million
0.207x +103.10%
2018-12-31 Rp2.37 Trillion
≈ $138.86 Million
Rp241.67 Billion
≈ $14.16 Million
0.102x -79.03%
2017-12-31 Rp956.53 Billion
≈ $56.05 Million
Rp465.08 Billion
≈ $27.25 Million
0.486x +68.84%
2016-12-31 Rp1.26 Trillion
≈ $73.83 Million
Rp362.85 Billion
≈ $21.26 Million
0.288x +7.84%
2015-12-31 Rp957.59 Billion
≈ $56.11 Million
Rp255.71 Billion
≈ $14.98 Million
0.267x --

About Medikaloka Hermina PT

JK:HEAL Indonesia Medical Care Facilities
Market Cap
$720.31 Million
Rp12.29 Trillion IDR
Market Cap Rank
#10224 Global
#110 in Indonesia
Share Price
Rp800.00
Change (1 day)
+0.63%
52-Week Range
Rp765.00 - Rp1760.00
All Time High
Rp971874.91
About

PT Medikaloka Hermina Tbk, together with its subsidiaries, operates a network of hospitals in Indonesia. The company offers services in the areas of medical acupuncture, pediatrics, surgery, orthopedic surgery, plastic and reconstructive surgery, emergency medicine, forensic and medicolegal, dentistry, clinical nutrition, integrative medicine, cardiology, obstetrics and gynecology, nuclear medici… Read more